Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Other Non-Current Assets (2016 - 2025)

Iradimed (IRMD) has disclosed Other Non-Current Assets for 13 consecutive years, with $214374.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Assets rose 16.37% to $214374.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $214374.0, a 16.37% increase, with the full-year FY2024 number at $198912.0, up 9.62% from a year prior.
  • Other Non-Current Assets was $214374.0 for Q3 2025 at Iradimed, up from $204499.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $648672.0 in Q4 2022 to a low of $172272.0 in Q1 2022.
  • A 5-year average of $244709.6 and a median of $204499.0 in 2025 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: skyrocketed 222.2% in 2022, then plummeted 72.03% in 2023.
  • Iradimed's Other Non-Current Assets stood at $201325.0 in 2021, then surged by 222.2% to $648672.0 in 2022, then tumbled by 72.03% to $181449.0 in 2023, then increased by 9.62% to $198912.0 in 2024, then increased by 7.77% to $214374.0 in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Other Non-Current Assets are $214374.0 (Q3 2025), $204499.0 (Q2 2025), and $206009.0 (Q1 2025).